ストックスクリーナーアプリを入手
32.39
0.25%
-0.08
前日終値:
$32.31
開ける：
$32.16
24時間の取引高:
174.04K
Relative Volume:
0.04
時価総額：
$13.64B
収益：
$2.26B
当期純損益:
$1.09B
株価収益率:
13.82
EPS:
2.3431
ネットキャッシュフロー:
$2.70B
1週間 パフォーマンス:
-5.26%
1か月 パフォーマンス:
+1.70%
6か月 パフォーマンス:
+21.94%
1年 パフォーマンス:
+20.04%
1日の値動き範囲:
$32.15
$32.39
1週間の範囲:
$32.15
$34.31
52週間の値動き範囲:
$24.05
$34.31
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
32.36 | 13.96B | 2.26B | 1.09B | 2.70B | 2.3431 |
|
ONC
Beigene Ltd Adr
|
238.63 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.42 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.33 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.60 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
72.77 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-16 | 開始されました | Morgan Stanley | Overweight |
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Raiffeisen Bank International AG Acquires Shares of 20,000 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Challenging Environment For Biopharma Is A Tailwind For Royalty Pharma - insights.citeline.com
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Man Group plc - MarketBeat
Point72 Asset Management L.P. Sells 277,630 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Two Sigma Investments LP Cuts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Holdings Trimmed by Captrust Financial Advisors - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Two Sigma Advisers LP - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by Ethic Inc. - MarketBeat
Royalty Pharma at RBC Capital Markets: Strategic Funding Insights By Investing.com - Investing.com Nigeria
Transcript : Royalty Pharma plc Presents at RBC Capital Markets Global Healthcare Conference 2025, May-20-2025 04 - marketscreener.com
Occudo Quantitative Strategies LP Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives $42.50 Consensus PT from Analysts - Defense World
OMERS ADMINISTRATION Corp Trims Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Patient Capital Management LLC Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma completes major acquisition By Investing.com - Investing.com Canada
Royalty Pharma completes major acquisition - Investing.com
Balyasny Asset Management L.P. Purchases Shares of 59,755 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by Bank of America Corp DE - MarketBeat
Royalty Pharma Completes RP Management Acquisition - citybiz
Baird Financial Group Inc. Acquires New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Deutsche Bank AG Buys 847,704 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Morgan Stanley Initiates Coverage on Royalty Pharma (NASDAQ:RPRX) - Defense World
Royalty Pharma (NASDAQ:RPRX) Stock Rating Upgraded by StockNews.com - MarketBeat
Royalty Pharma Closes Acquisition of External Manager - marketscreener.com
Royalty Pharma plc Completes Internalization of Management Structure with Overwhelming Shareholder Support - Nasdaq
Royalty Pharma Completes the Acquisition of Its External Manager - The Manila Times
Royalty Pharma Completes The Acquisition Of Its External Manager - marketscreener.com
Royalty Pharma's Major Transformation: External Manager Acquisition Promises Significant Cost Savings - Stock Titan
Royalty pharma projects 6-12% growth in 2025 portfolio receipts with $2B share buyback plan - MSN
Morgan Stanley reinstates Royalty Pharma with Overweight rating By Investing.com - Investing.com Nigeria
Morgan Stanley Reinstates Royalty Pharma (RPRX) at Overweight - StreetInsider
D. E. Shaw & Co. Inc. Has $29.63 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma at Bank of America 2025 Healthcare: Strategic Growth Insights - Investing.com Nigeria
Learn to Evaluate (RPRX) using the Charts - news.stocktradersdaily.com
BNP Paribas Financial Markets Makes New $41.96 Million Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Axa S.A. Acquires 138,017 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Crestline Management LP Acquires 79,532 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Bridgefront Capital LLC Invests $311,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma to Present at Upcoming Investor Conferences - The Manila Times
Stifel Financial Corp Has $438,000 Stake in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
13.67%
大文字化:
|
ボリューム (24 時間):